Publications by authors named "Huang Shuxiang"

Thrombosis represents the leading cause of death and disability upon major adverse cardiovascular events (MACEs). Numerous pathological conditions such as COVID-19 and metabolic disorders can lead to a heightened thrombotic risk; however, the underlying mechanisms remain poorly understood. Our study illustrates that 2-methylbutyrylcarnitine (2MBC), a branched-chain acylcarnitine, is accumulated in patients with COVID-19 and in patients with MACEs.

View Article and Find Full Text PDF

Human coronavirus 229E (HCoV-229E) and NL63 (HCoV-NL63) are endemic causes of upper respiratory infections such as the "common cold" but may occasionally cause severe lower respiratory tract disease in the elderly and immunocompromised patients. There are no approved antiviral drugs or vaccines for these common cold coronaviruses (CCCoV). The recent emergence of COVID-19 and the possible cross-reactive antibody and T cell responses between these CCCoV and SARS-CoV-2 emphasize the need to develop experimental animal models for CCCoV.

View Article and Find Full Text PDF

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic is currently the major challenge to global public health. Two proteases, papain-like protease (PLpro) and the 3-chymotrypsin-like protease (3CLpro or Mpro), are indispensable for SARS-CoV-2 replication, making them attractive targets for antiviral therapy development. Here we screened a panel of essential metal ions using a proteolytic assay and identified that zinc gluconate, a widely-used zinc supplement, strongly inhibited the proteolytic activities of the two proteases in vitro.

View Article and Find Full Text PDF

The current COVID-19 pandemic, caused by SARS-CoV-2, poses a serious public health threat. Effective therapeutic and prophylactic treatments are urgently needed. Angiotensin-converting enzyme 2 (ACE2) is a functional receptor for SARS-CoV-2, which binds to the receptor binding domain (RBD) of SARS-CoV-2 spike protein.

View Article and Find Full Text PDF
Article Synopsis
  • Virus-specific T cells are crucial for defending against various virus infections, including SARS-CoV and MERS-CoV.
  • This study used mice infected with SARS-CoV-2 to identify specific T cell responses and revealed that these T cells can effectively target and kill infected cells while relying on the type I interferon pathway for generating strong antiviral responses.
  • The findings also highlighted that T cell vaccination provided some protection against severe COVID-19 in mice and showed cross-reactive responses between SARS-CoV and SARS-CoV-2, which can inform future vaccine development and understanding of COVID-19 disease mechanisms.
View Article and Find Full Text PDF

COVID-19, caused by SARS-CoV-2, is a virulent pneumonia, with >4,000,000 confirmed cases worldwide and >290,000 deaths as of May 15, 2020. It is critical that vaccines and therapeutics be developed very rapidly. Mice, the ideal animal for assessing such interventions, are resistant to SARS-CoV-2.

View Article and Find Full Text PDF

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe acute respiratory disease in humans. MERS-CoV strains from early epidemic clade A and contemporary epidemic clade B have not been phenotypically characterized to compare their abilities to infect cells and mice. We isolated the clade B MERS-CoV ChinaGD01 strain from a patient infected during the South Korean MERS outbreak in 2015 and compared the phylogenetics and pathogenicity of MERS-CoV EMC/2012 (clade A) and ChinaGD01 (clade B) and Genome alignment analysis showed that most clade-specific mutations occurred in the orf1ab gene, including mutations that were predicted to be potential glycosylation sites.

View Article and Find Full Text PDF

SARS-CoV-2 caused a major outbreak of severe pneumonia (COVID-19) in humans. Viral RNA was detected in multiple organs in COVID-19 patients. However, infectious SARS-CoV-2 was only isolated from respiratory specimens.

View Article and Find Full Text PDF
Article Synopsis
  • Lianhuaqingwen (LH) is a traditional Chinese medicine that has shown antiviral effects against influenza and is now being studied for its efficacy against the SARS-CoV-2 virus.
  • The study found that LH significantly inhibits the replication of SARS-CoV-2 in cells and reduces the production of pro-inflammatory cytokines associated with the virus.
  • These findings suggest that LH could be an effective treatment option for COVID-19, as it not only prevents virus replication but also reduces inflammation in the body.
View Article and Find Full Text PDF

Category induction involves abstraction of features common to two or more stimuli. Event-related potentials (ERPs) during induction and non-induction tasks were recorded for 12 children and 12 adults. We found that (1) ERP waves, except P2 amplitude, decreased significantly with age, (2) Compared to non-induction tasks, induction tasks elicited larger fronto-central N2 components in both age groups, (3) The amplitude of the late positive component was significantly greater in the induction condition than in the non-induction condition, and (4) The difference wave suggested that category induction was mainly located in the left hemisphere in children but was not lateralized in adults.

View Article and Find Full Text PDF